Wanbury Ltd
NSE:WANBURY
Operating Margin
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Peer Comparison
| Country | Company | Market Cap |
Operating Margin |
||
|---|---|---|---|---|---|
| IN |
|
Wanbury Ltd
NSE:WANBURY
|
9.3B INR |
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
965.7B USD |
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
594B USD |
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
291.5B CHF |
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
236.4B GBP |
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
242.5B CHF |
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
303.7B USD |
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD |
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.4T DKK |
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
152.2B USD |
Loading...
|
|
| UK |
|
GSK plc
XETRA:GS71
|
105.9B EUR |
Loading...
|
Market Distribution
| Min | -153 833.3% |
| 30th Percentile | 2.7% |
| Median | 7.3% |
| 70th Percentile | 13.2% |
| Max | 9 977% |
Other Profitability Ratios
Wanbury Ltd
Glance View
Wanbury Ltd. engages in the business of pharmaceutical and related activities, including research. The company is headquartered in Navi Mumbai, Maharashtra. The firm is engaged in the business of pharmaceutical and related activities, including research. The firm operates through two divisions: Active Pharmaceutical Ingredients (API) Business and Domestic Formulations Business. The firm through Active Pharmaceutical Ingredients (API) Business provides Metformin and Sertraline. Metformin is used for the treatment of type-1 diabetes and Sertraline is an anti-depressant. The firm through Domestic Formulations Business offers brands, which include Coriminic range, Chymonac range, Adtrol Range, Cusena, Rabiplus range, Nurture, Senasof, Nifty-SR and Zeva. The firm's subsidiaries include Wanbury Holding B.V., Wanbury Global FZE (UAE) and Ningxia Wanbury Fine Chemicals Co. Ltd. (China). The company also provides Nurture-SF sugar-free protein supplements for Gestational diabetes mellitus (GDM) and Physicians (for diabetes/active lifestyle).
See Also
Operating Margin is calculated by dividing the Operating Income by the Revenue.
The current Operating Margin for Wanbury Ltd is 12.7%, which is above its 3-year median of 9.9%.
Over the last 3 years, Wanbury Ltd’s Operating Margin has decreased from 17.7% to 12.7%. During this period, it reached a low of 4% on Jun 30, 2023 and a high of 17.7% on Sep 30, 2022.
